Modification of myosin gene expression by imidapril in failing heart due to myocardial infarction

Journal of Molecular and Cellular Cardiology

Volumn 34, Issue 7, 2002, Pages 847-857

  Wang, Jingwei ^a   Liu, Xueliang ^a   Ren, Bin ^a   Rupp, Heinz ^a   Takeda, Nobuakira ^b   Dhalla, Naranjan S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Jikei University Katsushika Medical Center   (Japan)

Author keywords

Angiotensin converting enzyme inhibitor; Congestive heart failure; Myocardial infarction; Myofibrillar ATPase; Myosin heavy chain isoforms

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIDAPRIL; ISOPROTEIN; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE; MALE; MUSCLE FIBRIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RAT STRAIN;

ANIMALIA;

EID: 0036660651     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2002.2023     Document Type: Article

References (54)

1. Scheuer J, Bhan AK. Cardiac contractile proteins. Adenosine triphosphatase activity and physiological function. Circ Res 1979; 45: 1-12.
2. Eisenberg E, Greene LE. The relation of muscle biochemistry to muscle physiology. Annu Rev Physiol 1980; 42: 293-309.
3. Schwartz K, Lecarpentier Y, Martin JL, Lompre AM, Mercadier JJ, Swynghedauw B. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol 1981; 13: 1071-1075.
4. Mahdavi V, Periasamy M, Nadal-Ginard B. Molecular characterization of two myosin heavy chain genes expressed in the adult heart. Nature 1982; 297: 659-664.
5. Mahdavi V, Chambers AP, Nadal-Ginard B. Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci USA 1984; 81: 2626-2630.
6. Hoh JF, Mcgrath PA, Hale PT. Electrophoretic analysis of multiple forms of rat cardiac myosin: effects of hypophysectomy and thyroxine replacement. J Mol Cell Cardiol 1978; 10: 1053-1076.
7. Pope B, Hoh JF, Weeds A. The ATPase activities of rat cardiac myosin isoenzymes. FEBS Lett 1980; 118: 205-208.
8. Effron MB, Bhatnagar GM, Spurgeon HA, Ruano-Arroyo G, Lakatta EG. Changes in myosin isoenzymes. ATPase activity, and contraction duration in rat cardiac muscle with aging can be modulated by thyroxine. Circ Res 1987; 60: 238-245.
9. Cummins P, Lambert SJ. Myosin transitions in the bovine and human heart. A developmental and anatomical study of heavy and light chain subunits in the atrium and ventricle. Circ Res 1986; 58: 846-858.
10. Rupp H, Dietz K. Mathematical models of myosin heterodimer formation in the rat heart during thyroid hormone alterations. Circ Res 1991; 68: 27-37.
11. Iwanaga Y, Kihara Y, Yoneda T, Aoyama T, Sasayama S. Modulation of in vivo cardiac hypertrophy with insulin-like growth factor-1 and angiotensin-converting enzyme inhibitor: relationship between change in myosin isoform and progression of left ventricular dysfunction. J Am Coll Cardiol 2000; 36: 635-642.
12. Dhalla NS, Das PK, Sharma GP. Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol 1978; 10: 363-385.
13. Dhalla NS, Afzal N, Beamish RE, Naimark B, Takeda N, Nagano M. Pathophysiology of cardiac dysfunction in congestive heart failure. Can J Cardiol 1993; 9: 873-887.
14. Reiser PJ, Portman MA, Ning XH, Schomisch MC. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am J Physiol Heart Circ Physiol 2001; 280: H1814-H1820.
15. Pierce GN, Dhalla NS. Mechanisms of the defect in cardiac myofibrillar function during diabetes. Am J Physiol Endocrinol Metab 1985; 248: E170-E175.
16. Dillmann WH. Influence of thyroid hormone administration on myosin ATPase activity and myosin isoenzyme distribution in the heart of diabetic rats. Metabolism 1982; 31: 199-204.
17. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, Mckenna WJ, Schiaffino S. Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992; 85: 1734-1742.
18. Geenen DL, White TP, Lampman RM. Papillary mechanics and cardiac morphology of infarcted rat hearts after training. J Appl Physiol 1987; 63: 92-96.
19. Geenen DL, Malhotra A, Scheuer J. Regional variation in rat cardiac myosin isoenzymes and ATPase activity after infarction. Am J Physiol Heart Circ Physiol 1989; 256: H745-H750.
20. Ojamaa K, Kenessey A, Shenoy R, Klein I. Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat. Am J Physiol Endocrinol Metab 2000; 279: E1319-E1324.
21. Shimada T, Yoshiyama M, Takeuchi K, Omura T, Takemoto Y, Kim S, Iwao H, Yoshikawa J. Long acting calcium antagonist amlodipine prevents left ventricular remodeling after myocardial infarction in rats. Cardiovasc Res 1998; 37: 618-626.
22. Takeuchi K, Omura T, Yoshiyama M, Yoshida K, Otsuka R, Shimada Y, Ujino K, Yoshikawa J. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats. Heart Vessels 1999; 14: 111-119.
23. Hanatani A, Yoshiyama M, Takeuchi K, Kim S, Nakayama K, Omura T, Iwao H, Yoshikawa J. Angiotensin II type 1-receptor antagonist candesartan cilexitil prevents left ventricular dysfunction in myocardial infarcted rats. Jpn J Pharmacol 1998; 78: 45-54.
24. Gidh-Jain M, Huang B, Jain P, Gick G, El-Sherif N. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction. J Mol Cell Cardiol 1998; 30: 627-637.
25. Daniels MC, Keller RS, de Tombe PP. Losartan prevents contractile dysfunction in rat myocardium after left ventricular myocardial infarction. Am J Physiol Heart Circ Physiol 2001; 281: H2150-H2158.
26. Mahaffey KW, Raya TE, Pennock GD, Morkin E, Goldman S. Left ventricular performance and remodeling in rabbits after myocardial infarction. Effects of a thyroid hormone analogue. Circulation 1995; 91: 794-801.
27. Dixon IMC, Lee SL, Dhalla NS. Nitrendipine binding in congestive heart failure due to myocardial infarction. Circ Res 1990; 66: 782-788.
28. Afzal N, Dhalla NS. Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol Heart Circ Physiol 1992; 262: H868-H874.
29. Sethi R, Dhalla KS, Beamish RE, Dhalla NS. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol Heart Circ Physiol 1997; 272: H884-H893.
30. Pfeffer JM, Pfeffer MA, Braunwald E. Hemodynamic benefits and prolonged survival with long-term captopril therapy in rats with myocardial infarction and heart failure. Circulation 1987; 75: I149-I155.
31. Tappia PS, Liu S-Y, Shatadal S, Takeda N, Dhalla NS, Panagia. V. Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: Partial correction by imidapril. Am J Physiol Heart Circ Physiol 1999; 277: H40-H49.
32. 2+-transport in heart failure due to myocardial infarction. J Mol Cell Cardiol 1999; 31: 1663-1672.
33. Ogiku N, Sumikawa H, Nishimura T, Narita H, Ishida R. Reduction of the mortality rate by imidapril in a small coronary artery disease model (NZW x BXSB) F1 male mice. Jpn J Pharmacol 1994; 64: 129-133.
34. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanataphenol-chlorofom extraction. Anal Biochem 1987; 162: 156-159.
35. Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehype-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 2485-2502.
36. Persechini A, Stull JT. Phosphorylation kinetics of skeletal muscle myosin and the effect of phosphorylation on actomyosin adenosine triphosphatase activity. Biochemistry 1984; 23: 4144-4150.
37. Liu X, Shao Q, Dhalla NS. Myosin light chain phosphorylation in cardiac hypertrophy and failure due to myocardial infarction. J Mol Cell Cardiol 1995; 27: 2613-2621.
38. Sethi R, Elimban V, Chapman D, Dixon IMC, Dhalla NS. Differential alterations in left and right ventricular G-proteins in congestive heart failure due to myocardial infarction. J Mol Cell Cardiol 1998; 30: 2153-2163.
39. Hill MF, Singal PK. Right and left myocardial antioxidant responses during heart failure subsequent to myocardial infarction. Circulation 1997; 96: 2414-2420.
40. Palace V, Kumar D, Hill MF, Khaper N, Singal PK. Regional differences in non-enzymatic antioxidants in the heart under control and oxidative stress conditions. J Mol Cell Cardiol 1999; 31: 193-202.
41. Ganguly PK, Dhalla KS, Shao Q, Beamish RE, Dhalla NS. Differential changes in sympathetic activity in left and right ventricles in congestive heart failure following myocardial infarction. Am Heart J 1997; 133: 340-345.
42. Michel J-W, Lattion J-L, Salzmann J-L, De Lourdes Cerol M, Philippe M, Camilleri J-P, Corvol, P. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ Res 1998; 62: 641-650.
43. Sanbe A, Tanonaka K, Kobayasi R, Takeo S. Effects of long-term therapy with ACE inhibitors, captopril, enalapril and trandolapril, on myocardial energy metabolism in rats with heart failure following myocardial infarction. J Mol Cell Cardiol 1995; 27: 2209-2222.
44. Linz W, Scholkens BA. A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril. Br J Pharmacol 1992; 105: 771-772.
45. Gohlke P, Linz W, Scholkens BA, Kuwer I, Bartenbach S, Schnell A, Unger T. Angiotensin-converting enzyme inhibition improves cardiac function: role of bradykinin. Hypertension 1994; 23: 411-418.
46. Khaper N, Singal PK. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J Am Coll Cardiol 2001; 37: 1461-1466.
47. Sharma SK, Chapman D, Temsah R, Netticadan T, Brasil DP, Dhalla NS. Prevention of vascular apoptosis in myocardial infarction by losartan. J Cardiovasc Pharmacol Therapeut 1999; 4: 77-84.
48. Dhalla NS, Wang X, Beamish RE. Intracellular calcium handling in normal and failing hearts. Exp Clin Cardiol 1996; 1: 7-20.
49. Dhalla NS, Shao Q, Panagia V. Remodeling of cardiac membranes during the development of congestive heart failure. Heart Failure Reviews 1998; 2: 261-272.
50. Anand IS, Liu D, Chugh SS, Prahash AJC, Gupta S, John R, Popescu F, Chandrashekhar Y. Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction. Circulation 1997; 96: 3974-3984.
51. Cheung JY, Musch TI, Misawa H, Semanchick A, Elensky M, Yelamarty RV, Moore RL. Impaired cardiac function in rats with healed myocardial infarction: cellular vs myocardial mechanisms. Am J Physiol Cell Physiol 1994; 266: C29-C36.
52. Li P, Park C, Micheletti R, Li B, Cheng W, Sonnenblick EH, Anversa P, Bianchi G. Myocyte performance during evolution of myocardial infarction in rats: effects of propionyl-L-carnitine. Am J Physiol Heart Circ Physiol 1995; 268: H1702-H1713.
53. Lefroy DC, Crake T, Delmonte F, Vescovo G, Libera LD, Harding S, Poole-Wilson PA. Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts. Am J Physiol Heart Circ Physiol 1996; 270: H2060-H2069.
54. Wolfel EE, Lowes BD, Minobe WA, Lindenfeld JA, Shakar S, Robertson AD. Molecular and physiologic determinants of improvement in functional capacity in subjects treated with β-adrenergic blocking agents. Circulation 2001; 104 (Suppl II): II-342.